These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 34170791)

  • 1. Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management.
    Simonetti O; Radi G; Molinelli E; Rizzetto G; Diotallevi F; Offidani A
    Hum Vaccin Immunother; 2021 Oct; 17(10):3268-3275. PubMed ID: 34170791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants and Effectiveness of BNT162b2 mRNA Vaccination Among Patients with Atopic Dermatitis: A Population-Based Study.
    Kridin K; Schonmann Y; Onn E; Bitan DT; Weinstein O; Cohen AD
    Am J Clin Dermatol; 2022 May; 23(3):385-392. PubMed ID: 35294720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Atopic Dermatitis During the COVID-19 Pandemic: Key Questions and Review of the Current Evidence.
    Wu PC; Li CL; Chang YT; Chen CC; Wu CY; Ma SH
    Dermatitis; 2023; 34(2):77-84. PubMed ID: 36917535
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccines for COVID-19 in patients with atopic dermatitis: three things every dermatologist should know.
    Diotallevi F; Simonetti O; Radi G; Molinelli E; Rizzetto G; Cirioni O; D'Errico MM; Offidani A
    Acta Dermatovenerol Alp Pannonica Adriat; 2021 Jun; 30(2):67-69. PubMed ID: 34169702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry.
    Chiricozzi A; Talamonti M; De Simone C; Galluzzo M; Gori N; Fabbrocini G; Marzano AV; Girolomoni G; Offidani A; Rossi MT; Bianchi L; Cristaudo A; Fierro MT; Stingeni L; Pellacani G; Argenziano G; Patrizi A; Pigatto P; Romanelli M; Savoia P; Rubegni P; Foti C; Milanesi N; Belloni Fortina A; Bongiorno MR; Grieco T; Di Nuzzo S; Fargnoli MC; Carugno A; Motolese A; Rongioletti F; Amerio P; Balestri R; Potenza C; Micali G; Patruno C; Zalaudek I; Lombardo M; Feliciani C; Di Nardo L; Guarneri F; Peris K;
    Allergy; 2021 Jun; 76(6):1813-1824. PubMed ID: 34152613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
    Wharton M; Strikas RA; Harpaz R; Rotz LD; Schwartz B; Casey CG; Pearson ML; Anderson LJ; ;
    MMWR Recomm Rep; 2003 Apr; 52(RR-7):1-16. PubMed ID: 12710832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of SARS-CoV-2 Virus Infection on the Course of Atopic Dermatitis in Patients.
    Miodońska M; Bogacz A; Mróz M; Mućka S; Bożek A
    Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34067403
    [No Abstract]   [Full Text] [Related]  

  • 8. [Impact of COVID-19 Pandemic on Patients with Atopic Dermatitis].
    Pourani MR; Ganji R; Dashti T; Dadkhahfar S; Gheisari M; Abdollahimajd F; Dadras MS
    Actas Dermosifiliogr; 2022 Mar; 113(3):T286-T293. PubMed ID: 34565802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of COVID-19 Pandemic on Patients with Atopic Dermatitis.
    Pourani MR; Ganji R; Dashti T; Dadkhahfar S; Gheisari M; Abdollahimajd F; Shahidi Dadras M
    Actas Dermosifiliogr; 2022 Mar; 113(3):286-293. PubMed ID: 35153299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination.
    Naleway AL; Belongia EA; Greenlee RT; Kieke BA; Chen RT; Shay DK
    Ann Intern Med; 2003 Jul; 139(1):1-7. PubMed ID: 12834312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination Recommendations for Psoriasis and Atopic Dermatitis Patients on Biologic Therapy: A Practical Guide.
    Fan R; Cohen JM
    Yale J Biol Med; 2022 Jun; 95(2):249-255. PubMed ID: 35782480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccines: What dermatologists should know?
    Ayatollahi A; Hosseini H; Firooz R; Firooz A
    Dermatol Ther; 2021 Sep; 34(5):e15056. PubMed ID: 34232548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.
    Zhu FC; Li YH; Guan XH; Hou LH; Wang WJ; Li JX; Wu SP; Wang BS; Wang Z; Wang L; Jia SY; Jiang HD; Wang L; Jiang T; Hu Y; Gou JB; Xu SB; Xu JJ; Wang XW; Wang W; Chen W
    Lancet; 2020 Jun; 395(10240):1845-1854. PubMed ID: 32450106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Various aspects of the relationship between vitiligo and the COVID-19 pandemic or SARS-CoV-2 vaccines: Clinical pearls for dermatologists.
    Aryanian Z; Balighi K; Hatami P; Goodarzi A; Janbakhsh A; Afshar ZM
    J Cosmet Dermatol; 2023 Apr; 22(4):1152-1156. PubMed ID: 36762373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could live attenuated vaccines better control COVID-19?
    Okamura S; Ebina H
    Vaccine; 2021 Sep; 39(39):5719-5726. PubMed ID: 34426024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Care for children with atopic dermatitis in the Netherlands during the COVID-19 pandemic: Lessons from the first wave and implications for the future.
    Ragamin A; de Wijs LEM; Hijnen DJ; Arends NJT; Schuttelaar MLA; Pasmans SGMA; Bronner MB
    J Dermatol; 2021 Dec; 48(12):1863-1870. PubMed ID: 34459024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atopic dermatitis is not associated with SARS-CoV-2 outcomes.
    Rakita U; Kaundinya T; Guraya A; Nelson K; Maner B; Manjunath J; Schwartzman G; Lane B; Silverberg JI
    Arch Dermatol Res; 2022 Dec; 314(10):999-1002. PubMed ID: 34533589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the COVID-19 Pandemic on Atopic Dermatitis Patients.
    Sieniawska J; Lesiak A; Ciążyński K; Narbutt J; Ciążyńska M
    Int J Environ Res Public Health; 2022 Feb; 19(3):. PubMed ID: 35162757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis.
    von Sonnenburg F; Perona P; Darsow U; Ring J; von Krempelhuber A; Vollmar J; Roesch S; Baedeker N; Kollaritsch H; Chaplin P
    Vaccine; 2014 Sep; 32(43):5696-702. PubMed ID: 25149431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.